Some studies showed that ephrin-B2 is a poor prognostic indicator of solid tumors, including head-and-neck squamous cell carcinoma, pancreatic adenocarcinoma, bladder urothelial carcinoma, and thyroid carcinoma [14, 17–19]. This evidence concerns the gene EFNB2 and head and neck squamous cell carcinoma.